Approachable Synthetic Methodologies for Second-Generation β-Lactamase Inhibitors: A Review
Pharmaceuticals · 23.08.2024 · 17 (9) · 1108
DOI: 10.3390/ph17091108 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmaceuticals, online erschienen am 23.08.2024. Verfasst von Noor Fatima und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Government College University, Faisalabad 38000, Pakistan. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 179 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Some antibiotics that are frequently employed are β-lactams. In light of the hydrolytic process of β-lactamase, found in Gram-negative bacteria, inhibitors of β-lactamase (BLIs) have been produced. Examples of first-generation β-lactamase inhibitors include sulbactam, clavulanic acid, and tazobactam. Many kinds of bacteria immune to inhibitors have appeared, and none cover all the β-lactamase classes. Various methods have been utilized to develop second-generation β-lactamase inhibitors possessing new structures and facilitate the formation of diazabicyclooctane (DBO), cyclic boronate, metallo-, and dual-nature β-lactamase inhibitors. This review describes numerous promising second-generation β-lactamase inhibitors, including vaborbactam, avibactam, and cyclic boronate serine-β-lactamase inhibitors. Furthermore, it covers developments and methods for synthesizing MβL (metallo-β-lactamase inhibitors), which are clinically effective, as well as the various dual-nature-based inhibitors of β-lactamases that have been developed. Several combinations are still only used in preclinical or clinical research, although only a few are currently used in clinics. This review comprises materials on the research progress of BLIs over the last five years. It highlights the ongoing need to produce new and unique BLIs to counter the appearance of multidrug-resistant bacteria. At present, second-generation BLIs represent an efficient and successful strategy.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Chemistry, Government College University, Faisalabad 38000, Pakistan.
- Chemistry Department, Faculty of Science, King Khalid University, P.O. Box 9004, Abha 61413, Saudi Arabia.
- Faculty of Medicine, Transylvania University of Brasov, 500036 Brasov, Romania.
ORCID-Profile: Shehla Khalid, Nasir Rasool, Muhammad Imran, Bushra Parveen, Aqsa Kanwal, Codrut Ioan Ciurea
Zitieren
APA
Fatima, N., Khalid, S., Rasool, N., Imran, M., Parveen, B., Kanwal, A., Irimie, M., & Ciurea, C. I. (2024). Approachable Synthetic Methodologies for Second-Generation β-Lactamase Inhibitors: A Review. Pharmaceuticals, 17(9), 1108. https://doi.org/10.3390/ph17091108
Vancouver
Fatima N, Khalid S, Rasool N, Imran M, Parveen B, Kanwal A, et al. Approachable Synthetic Methodologies for Second-Generation β-Lactamase Inhibitors: A Review. Pharmaceuticals. 2024;17(9):1108. doi:10.3390/ph17091108
BibTeX
@article{Fatima2024,
author = {Fatima, Noor and Khalid, Shehla and Rasool, Nasir and Imran, Muhammad and Parveen, Bushra and Kanwal, Aqsa and Irimie, Marius and Ciurea, Codrut Ioan},
title = {Approachable Synthetic Methodologies for Second-Generation β-Lactamase Inhibitors: A Review},
journal = {Pharmaceuticals},
year = {2024},
volume = {17},
number = {9},
pages = {1108},
doi = {10.3390/ph17091108}
}
EUVIMED